Loncar Cancer Immunotherapy ETF’s (CNCR) Moving Averages Convergence Divergence (MACD) indicator is -0.12, suggesting Loncar Cancer Immunotherapy ETF is a Buy.
Loncar Cancer Immunotherapy ETF’s (CNCR) 20-Day exponential moving average is 9.51, making it a Sell.
Loncar Cancer Immunotherapy ETF’s (CNCR) 50-Day exponential moving average is 10.03, making it a Sell.